Robertson GL. Diabetes insipidus. Endocrinol Metab Clin North Am. 1995;24(3):549–72. (In eng).
Article CAS PubMed Google Scholar
Land H, Schütz G, Schmale H, Richter D. Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor. Nature. 1982;295(5847):299–303. https://doi.org/10.1038/295299a0. (In eng).
Article CAS PubMed Google Scholar
Levy B, Chauvet MT, Chauvet J, Acher R. Ontogeny of bovine neurohypophysial hormone precursors. II. Foetal copeptin, the third domain of the vasopressin precursor. Int J Pept Protein Res. 1986;27(3):320–4. (In eng).
Article CAS PubMed Google Scholar
Fenske W, Refardt J, Chifu I, et al. A copeptin-based Approach in the diagnosis of Diabetes insipidus. N Engl J Med. 2018;379(5):428–39.
Article CAS PubMed Google Scholar
Winzeler B, Cesana-Nigro N, Refardt J, et al. Arginine-stimulated copeptin measurements in the differential diagnosis of Diabetes insipidus: a prospective diagnostic study. Lancet. 2019;394(10198):587–95.
Article CAS PubMed Google Scholar
Atila C, Gaisl O, Vogt DR, Werlen L, Szinnai G, Christ-Crain M. Glucagon-stimulated copeptin measurements in the differential diagnosis of Diabetes insipidus: a double-blind, randomized, placebo-controlled study. Eur J Endocrinol. 2022;187(1):65–74. https://doi.org/10.1530/eje-22-0033. (In eng).
Article CAS PubMed Google Scholar
Prentice M. Time for change: renaming Diabetes insipidus to improve patient safety. Clin Endocrinol (Oxf). 2018;88(5):625–6. https://doi.org/10.1111/cen.13578. (In eng).
Atila C, Loughrey PB, Garrahy A, et al. Central Diabetes insipidus from a patient’s perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey. Lancet Diabetes Endocrinol. 2022;10(10):700–9. https://doi.org/10.1016/s2213-8587(22)00219-4. (In eng).
Arima H, Cheetham T, Christ-Crain M, et al. Changing the name of Diabetes insipidus: a position statement of the Working Group for Renaming Diabetes Insipidus. Eur J Endocrinol. 2022;187(5):P1–p3. https://doi.org/10.1530/eje-22-0751. (In eng).
Article CAS PubMed Google Scholar
Babey M, Kopp P, Robertson GL. Familial forms of Diabetes insipidus: clinical and molecular characteristics. Nat Rev Endocrinol. 2011;7(12):701–14. https://doi.org/10.1038/nrendo.2011.100. (In eng).
Article CAS PubMed Google Scholar
Fujiwara TM, Bichet DG. Molecular biology of hereditary Diabetes insipidus. J Am Soc Nephrol. 2005;16(10):2836–46. https://doi.org/10.1681/asn.2005040371. (In eng).
Article CAS PubMed Google Scholar
Miller M, Dalakos T, Moses AM, Fellerman H, Streeten DH. Recognition of partial defects in antidiuretic hormone secretion. Ann Intern Med. 1970;73(5):721–9. https://doi.org/10.7326/0003-4819-73-5-721. (In eng).
Article CAS PubMed Google Scholar
Rivier C, Vale W. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature. 1983;305(5932):325–7. https://doi.org/10.1038/305325a0. (In eng).
Article CAS PubMed Google Scholar
Gillies GE, Linton EA, Lowry PJ. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature. 1982;299(5881):355–7. https://doi.org/10.1038/299355a0. (In eng).
Article CAS PubMed Google Scholar
Nagy G, Mulchahey JJ, Smyth DG, Neill JD. The glycopeptide moiety of vasopressin-neurophysin precursor is neurohypophysial prolactin releasing factor. Biochem Biophys Res Commun. 1988;151(1):524–9. https://doi.org/10.1016/0006-291x(88)90625-0. (In eng).
Article CAS PubMed Google Scholar
Hyde JF, Ben-Jonathan N. The posterior pituitary contains a potent prolactin-releasing factor: in vivo studies. Endocrinology. 1989;125(2):736–41. https://doi.org/10.1210/endo-125-2-736. (In eng).
Article CAS PubMed Google Scholar
Barat C, Simpson L, Breslow E. Properties of human vasopressin precursor constructs: inefficient monomer folding in the absence of copeptin as a potential contributor to Diabetes insipidus. Biochemistry. 2004;43(25):8191–203. https://doi.org/10.1021/bi0400094. (In eng).
Article CAS PubMed Google Scholar
Wun T. Vasopressin and platelets: a concise review. Platelets. 1997;8(1):15–22. https://doi.org/10.1080/09537109777492. (In eng).
Article CAS PubMed Google Scholar
Preibisz JJ, Sealey JE, Laragh JH, Cody RJ, Weksler BB. Plasma and platelet vasopressin in Essential Hypertension and Congestive Heart Failure. Hypertension. 1983;5(2 Pt 2):I129–38. https://doi.org/10.1161/01.hyp.5.2_pt_2.i129. (In eng).
Article CAS PubMed Google Scholar
Jane Ellis M, Livesey JH, Evans MJ. Hormone stability in human whole blood. Clin Biochem. 2003;36(2):109–12. https://doi.org/10.1016/s0009-9120(02)00440-x. (In eng).
Article CAS PubMed Google Scholar
Baumann G, Dingman JF. Distribution, blood transport, and degradation of antidiuretic hormone in man. J Clin Invest. 1976;57(5):1109–16. https://doi.org/10.1172/jci108377. (In eng).
Article CAS PubMed PubMed Central Google Scholar
Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem. 2006;52(1):112–9. https://doi.org/10.1373/clinchem.2005.060038. (In eng).
Article CAS PubMed Google Scholar
Balanescu S, Kopp P, Gaskill MB, Morgenthaler NG, Schindler C, Rutishauser J. Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and Hyperosmolar States. J Clin Endocrinol Metab. 2011;96(4):1046–52. https://doi.org/10.1210/jc.2010-2499. (In eng).
Article CAS PubMed Google Scholar
Fenske WK, Schnyder I, Koch G, et al. Release and decay kinetics of Copeptin vs AVP in response to osmotic alterations in healthy volunteers. J Clin Endocrinol Metab. 2018;103(2):505–13. https://doi.org/10.1210/jc.2017-01891. (In eng).
Bhandari SS, Loke I, Davies JE, Squire IB, Struck J, Ng LL. Gender and renal function influence plasma levels of copeptin in healthy individuals. Clin Sci (Lond). 2009;116(3):257–63. https://doi.org/10.1042/cs20080140. (In eng).
Article CAS PubMed Google Scholar
Darzy KH, Dixit KC, Shalet SM, Morgenthaler NG, Brabant G. Circadian secretion pattern of copeptin, the C-terminal vasopressin precursor fragment. Clin Chem. 2010;56(7):1190–1. https://doi.org/10.1373/clinchem.2009.141689. (In eng).
Article CAS PubMed Google Scholar
Beglinger S, Drewe J, Christ-Crain M. The circadian rhythm of Copeptin, the C-Terminal portion of Arginine Vasopressin. J Biomark. 2017;2017:4737082. https://doi.org/10.1155/2017/4737082. (In eng).
Article CAS PubMed Central Google Scholar
Walti C, Siegenthaler J, Christ-Crain M. Copeptin levels are Independent of ingested nutrient type after standardised meal administration–the CoMEAL study. Biomarkers. 2014;19(7):557–62. https://doi.org/10.3109/1354750x.2014.940504. (In eng).
Article CAS PubMed Google Scholar
Blum CA, Mirza U, Christ-Crain M, Mueller B, Schindler C, Puder JJ. Copeptin levels remain unchanged during the menstrual cycle. PLoS ONE. 2014;9(5):e98240. https://doi.org/10.1371/journal.pone.0098240. (In eng).
Article CAS PubMed PubMed Central Google Scholar
Sailer CO, Winzeler B, Nigro N, et al. Characteristics and outcomes of patients with profound hyponatraemia due to primary polydipsia. Clin Endocrinol (Oxf). 2017;87(5):492–9. https://doi.org/10.1111/cen.13384. (In eng).
Article CAS PubMed Google Scholar
Arslan A, Karaarslan E, Dinçer A. High intensity signal of the posterior pituitary. A study with horizontal direction of frequency-encoding and fat suppression MR techniques. Acta Radiol. 1999;40(2):142–5. https://doi.org/10.3109/02841859909177729. (In eng).
Article CAS PubMed Google Scholar
Moses AM, Clayton B, Hochhauser L. Use of T1-weighted MR imaging to differentiate between primary polydipsia and central Diabetes insipidus. AJNR Am J Neuroradiol. 1992;13(5):1273–7. (In eng).
CAS PubMed PubMed Central Google Scholar
Côté M, Salzman KL, Sorour M, Couldwell WT. Normal dimensions of the posterior pituitary bright spot on magnetic resonance imaging. J Neurosurg. 2014;120(2):357–62. https://doi.org/10.3171/2013.11.Jns131320. (In eng).
Maghnie M, Cosi G, Genovese E, et al. Central Diabetes insipidus in children and young adults. N Engl J Med. 2000;343(14):998–1007. https://doi.org/10.1056/NEJM200010053431403. (In eng).
留言 (0)